Skip to main content
. 2017 Nov 18;8(64):107530–107542. doi: 10.18632/oncotarget.22501

Table 2. Correlation of the protein levels of the signaling molecules (p)ERK1/2, (p)AKT, pFAK (Y397) and SHC with integrin α5 expression in malign and benign tissue of patients with ccRCC.

tissue p-value
ERK1/2 malign 0.052
benign < 0.0001
pERK1/2 (T202/Y204) malign 0.058
benign 0.465
AKT malign 0.108
benign 0.279
pAKT (S473) malign 0.801
benign 0.133
pFAK (Y397) malign 0.049
benign 0.049
SHC malign 0.005
benign < 0.0001

Significance was calculated by a Spearman's Rho regression.